Platelet-activating factor stimulates receptor-mediated fromation of reactive oxygen intermediates in human monocytes M. G. PustynnikovN. V. PorodenkoE. S. Severin Cell Biology of PAF Pages: 1214 - 1217
Calcium channel blockade inhibits platelet activating factor production by human umbilical vein endothelial cells J. P. TolinsA. MelemedG. M. Vercellotti Cell Biology of PAF Pages: 1218 - 1222
The effect of eicosapentaenoic acid consumption on human neutrophil chemiluminescence Philip J. ThompsonNeil L. A. MissoMartin J. Phillips Cell Biology of PAF Pages: 1223 - 1226
Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes Shuji TakahashiToshikazu YoshikawaMotoharu Kondo Cell Biology of PAF Pages: 1227 - 1230
IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates Paloma HernandoJesus EgidoEva Gonzalez Cell Biology of PAF Pages: 1231 - 1235
Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: Intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system Nicolas G. BazanStephen P. SquintoVictor L. Marcheselli PAF and the Cerebral System Pages: 1236 - 1242
Calcium ion mobilization in neuronal cells induced by PAF Elizabeth KorneckiYigal H. Ehrlich PAF and the Cerebral System Pages: 1243 - 1246
Role of platelet-activating factor in aggregation of leukocytes and platelets in cerebral ischemia S. UchiyamaM. YamazakiS. Maruyama PAF and the Cerebral System Pages: 1247 - 1249
Cardiovascular effects of platelet-activating factor Robert E. GoldsteinGiora Z. FeuersteinNancy J. Davenport PAF, the Cardiovascular System, and Hypotension Pages: 1250 - 1256
Platelet-activating factor in cardiovascular stress situations Reuven RabinoviciTian-Li YueGiora Feuerstein PAF, the Cardiovascular System, and Hypotension Pages: 1257 - 1263
Studies on the role of platelet-activating factor in blood pressure regulation Katsuhiko SakaguchiShigeto MorimotoIsao Yamatsu PAF, the Cardiovascular System, and Hypotension Pages: 1264 - 1268
Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking Tada-atsu Imaizumi PAF, the Cardiovascular System, and Hypotension Pages: 1269 - 1273
Platelet-activating factor (PAF) induces contraction of saponin-skinned smooth muscle of coronary artery A. I. SolovievP. Braquet PAF, the Cardiovascular System, and Hypotension Pages: 1274 - 1276
Role for platelet-activating factor in asthma K. F. ChungP. J. Barnes PAF, the Respiratory System, Allergy, and Asthma Pages: 1277 - 1279
The contribution of platelet-activating factor to allergen-induced eosinophil infiltration and bronchial hyperresponsiveness C. P. Page PAF, the Respiratory System, Allergy, and Asthma Pages: 1280 - 1282
Platelet activating factor-induced pulmonary accumulation of111indium-oxine labelled neutrophils in anesthetized guinea pigs Ursula Hultkvist-BengtssonGary P. AndersonJohn Morley PAF, the Respiratory System, Allergy, and Asthma Pages: 1283 - 1286
Platelet activating factor induced respiratory mucosal damage Ken-ichi HisamatsuTetsuya GanboYoshihiko Murakami PAF, the Respiratory System, Allergy, and Asthma Pages: 1287 - 1291
Platelet-activating factor detected in bronchoalveolar lavage fluids from an asthmatic patient Tsugio HoriiHitoshi OkazakiKunihiko Saito PAF, the Respiratory System, Allergy, and Asthma Pages: 1292 - 1296
Platelet-activating factor (PAF) in allergic diseases: Inhibitory effects of anti-allergic drugs, ketotifen and three Kampo medicines on PAF production Tsuneyoshi NakamuraMotoaki KuriyamaTerumasa Miyamoto PAF, the Respiratory System, Allergy, and Asthma Pages: 1297 - 1300
Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs Masako UchidaNoriaki ImanishiShigeaki Morooka PAF, the Respiratory System, Allergy, and Asthma Pages: 1301 - 1304
Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 2. Effect on antigen-induced dual asthmatic response and infiltration of leukocytes into airways in actively sensitized conscious guinea pigs Toshinari SugasawaNoriaki ImanishiShigeaki Morooka PAF, the Respiratory System, Allergy, and Asthma Pages: 1305 - 1309
The role of platelet-activating factor (PAF) in experimental glomerular injury A. ArtizM. Gomez-ChiarriJ. Egido PAF and the Renal System Pages: 1310 - 1315
The effects of R-75,317 on antiglomerular basement membrane glomerulonephritis in rats Masaaki MiyamotoHiroyuki KoikeNorio Nakamura PAF and the Renal System Pages: 1316 - 1319
Nephrotoxicity of cyclosporine: The role of platelet-activating factor and thromboxane Oscar F. Pavão dos SantosMirian A. BoimNestor Schor PAF and the Renal System Pages: 1320 - 1323
Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin Oscar F. Pavão dos SantosMirian A. BoimNestor Schor PAF and the Renal System Pages: 1324 - 1328
Effects of PAF antagonists on renal vascular escape and tachyphylaxis in perfused rabbit kidney M. G. FerreiraP. BraquetM. C. Fonteles PAF and the Renal System Pages: 1329 - 1332
Presence of platelet-activating factor in pyuria in humans Ichiro IkedaMakoto OdaKojiro Yasunaga PAF and the Renal System Pages: 1333 - 1335
Significance of platelet-activating factor in mesenteric ischemia-reperfusion János FilepPierre BraquetTibor Mózes PAF and the Gastrointestinal System Pages: 1336 - 1339
Hypoxia, PAF, and necrotizing enterocolitis Michael S. CaplanXiao-Ming SunWei Hsueh PAF and the Gastrointestinal System Pages: 1340 - 1343
Antagonism of platelet-activating factor in isolated rat colon: Possible mechanism Akira TokumuraNobuyuki YubeHiroaki Tsukatani PAF and the Gastrointestinal System Pages: 1344 - 1346
Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress Junko SugataniKazuyo FujimuraKunihiko Saito PAF and the Gastrointestinal System Pages: 1347 - 1353
The effect of CV-3988 and CV-6209 on the acute gastric erosions of rats due to water-immersion and restraint stress Makoto NogamiYoshio HoshiharaJunji Shiga PAF and the Gastrointestinal System Pages: 1354 - 1355
Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat János FilepFerenc HermánPierre Braquet PAF and the Gastrointestinal System Pages: 1356 - 1358
Myoelectric intestinal disturbances inEscherichia coli endotoxic shock in rats. Involvement of platelet-activating factor Laurent PonsMarié-Thèrese Droy-LefaixLionel Buéno PAF and the Gastrointestinal System Pages: 1359 - 1361
Platelet-activating factor and granulocyte-mediated oxidative stress. Strategy forin vivo oxyradical visualization Makoto SuematsuMasaharu Tsuchiya Pathophysiology of PAF Pages: 1362 - 1368
Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists Hubert O. Heuer Pathophysiology of PAF Pages: 1369 - 1373
Effect of the hetrazepinoic platelet-activating factor antagonist bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs H. O. Heuer Pathophysiology of PAF Pages: 1374 - 1380
Platelet-activating factor type activity in plasma from patients with septicemia and other diseases Hubert O. HeuerHarald DariusNorbert Treese Pathophysiology of PAF Pages: 1381 - 1385
Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains Akinori ArimuraMinoru Harada Pathophysiology of PAF Pages: 1386 - 1390
Effect of a selective PAF antagonist SM-10661 ((±)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC) Noriaki ImanishiYoshihiro KomuroShigeaki Morooka Pathophysiology of PAF Pages: 1391 - 1395
Effect of PAF-acether antagonists on active anaphylactic mouse paw edema Claudia Zuany AmorimMaria das Graças Muller de Oliveira HenriquesB. Boris Vargaffig Pathophysiology of PAF Pages: 1396 - 1399
Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF) V. F. SagachA. V. DmitrievaP. Braquet Pathophysiology of PAF Pages: 1400 - 1403
Induction of platelet-activating factor in mice by intravenous administration of a neutral fraction of bakers' yeast mannan Takeshi MikamiKen FukushiMasuko Suzuki Pathophysiology of PAF Pages: 1404 - 1407
Involvement of platelet-activating factor in zymosan-induced rat pleurisy Yohsuke ImaiMasahiko HayashiSachiko Oh-ishi Pathophysiology of PAF Pages: 1408 - 1411
Hexadecylphosphocholine: Preclinical and the first clinical results of a new antitumor drug Clemens UngerHansjörg Eibl Alkyl Lysophospholipids in Cancer Therapy Pages: 1412 - 1417
Comparison of selective cytotoxicity of alkyl lysophospholipids W. R. VoglerA. C. OlsonH. Nomura Alkyl Lysophospholipids in Cancer Therapy Pages: 1418 - 1423
Stereospecific synthesis of antitumor active thioether PAF analogs Suresh K. BhatiaJoseph Hajdu Alkyl Lysophospholipids in Cancer Therapy Pages: 1424 - 1430
Antitumor activity of ilmofosine (BM 41.440) in the3Lewis-lung carcinoma model Dieter B. J. HerrmannHans-George OpitzPaul G. Munder Alkyl Lysophospholipids in Cancer Therapy Pages: 1431 - 1436
1-β-D-arabinofuranosylcytosine conjugates of ether and thioether phospholipids. A new class of ara-C prodrug with improved antitumor activity Chung Il HongCharles R. WestWolfgang E. Berdel Alkyl Lysophospholipids in Cancer Therapy Pages: 1437 - 1444
Induction of differentiation of human myeloid leukemia HL-60 cells by novel nonphosphorus alkyl ether lipids Yoshio HonmaTakashi KasukabeHiroaki Nomura Alkyl Lysophospholipids in Cancer Therapy Pages: 1445 - 1449